Serial Number | 98720113 |
Word Mark | KNOMATIC |
Filing Date | Tuesday, August 27, 2024 |
Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
Status Date | Tuesday, August 27, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | chemical and biochemical preparations and substances for medical purposes for treatment and/or diagnosis of cancer, autoimmune disease, and other diseases that involve the functionality of highly dynamic proteins; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders |
Goods and Services | drug discovery services; pharmaceutical research services; pharmaceutical products development; pharmaceutical research and development; pharmaceutical drug development services; consulting services in the field of pharmaceutical research and development; technical consulting in the field of pharmaceutical studies; technical research in the field of pharmaceutical studies; research and development services of new pharmaceutical products; research and development in the pharmaceutical and biotechnology fields; providing medical research information in the field of pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research in the field of bioinformatics; biological and bio-technology analysis services; DNA sequencing technology research; research in the field of DNA mutation; DNA analysis services for scientific research purposes; providing genetic science information; scientific research consulting in the field of pharmaceuticals and drug discovery; medical and scientific research in the field of proteomics; scientific research for medical purposes in the field of proteomics; structural and functional analysis of genomes; software as a service (SAAS) services in the nature of a drug discovery platform that utilizes structural analysis, hit finding techniques and computational analysis and targets diseases related to highly dynamic proteins; software as a service (SAAS) services in the nature of drug design and structure activity relationships; software as a service (SAAS) services featuring software for drug discovery, pharmaceutical research and development, and medical research and development; ยท software as a service (SAAS) services in the nature of DNA encoded library (DEL) screening; software as a service (SAAS) services in the nature of genetic sequencing software; software as a service (SAAS) services featuring software using artificial intelligence (AI) for drug discovery, pharmaceutical research and development, and medical research and development; software as a service (SAAS) services featuring software using machine learning for drug discovery, pharmaceutical research and development, and medical research and development; drug discovery software platform as a service particularly targeting diseases related to highly dynamic proteins by utilizing structural analysis, hit finding techniques and computational analysis; software as a service (SAAS) services for use in developing and prioritizing lead compounds for drug development; software as a service (SAAS) services in the field of biochemistry; software as a service (SAAS) services in the field of biophysics; software as a service (SAAS) services in the field of structural biology; software as a service (SAAS) services in the field of chemistry; software as a service (SAAS) services in the nature of a knowledge based drug discovery platform; software as a service (SAAS) services in the nature of data analysis software for use in drug discovery; software as a service (SAAS) services in the nature of drug discovery software utilizing hit finding techniques. |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, August 27, 2024 |
Primary Code | 005 |
First Use Anywhere Date | Monday, August 19, 2024 |
First Use In Commerce Date | Monday, August 19, 2024 |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, August 27, 2024 |
Primary Code | 042 |
First Use Anywhere Date | Monday, August 19, 2024 |
First Use In Commerce Date | Monday, August 19, 2024 |
Party Name | Moma Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Cambridge, MA 02140 |
Event Date | Event Description |
Tuesday, August 27, 2024 | NEW APPLICATION ENTERED |
Friday, January 17, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |